Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Telomere | 76 | 2024 | 924 | 8.810 |
Why?
|
Endometrial Neoplasms | 65 | 2024 | 1367 | 8.520 |
Why?
|
Leukocytes | 51 | 2024 | 2030 | 4.710 |
Why?
|
Genetic Predisposition to Disease | 80 | 2023 | 17684 | 1.860 |
Why?
|
Polymorphism, Genetic | 34 | 2015 | 4284 | 1.790 |
Why?
|
Polymorphism, Single Nucleotide | 77 | 2024 | 15669 | 1.580 |
Why?
|
Genome-Wide Association Study | 48 | 2024 | 12482 | 1.420 |
Why?
|
Case-Control Studies | 107 | 2024 | 21917 | 1.340 |
Why?
|
Telomerase | 10 | 2023 | 743 | 1.270 |
Why?
|
DNA, Mitochondrial | 11 | 2023 | 849 | 1.170 |
Why?
|
Aging | 26 | 2024 | 8595 | 1.080 |
Why?
|
Receptors, Progesterone | 6 | 2017 | 1116 | 1.020 |
Why?
|
Nurses | 19 | 2017 | 2460 | 0.950 |
Why?
|
Urinary Bladder Neoplasms | 16 | 2023 | 2271 | 0.880 |
Why?
|
DNA Copy Number Variations | 11 | 2023 | 2004 | 0.830 |
Why?
|
Genotype | 53 | 2024 | 12876 | 0.830 |
Why?
|
Adenocarcinoma | 10 | 2016 | 6317 | 0.800 |
Why?
|
Body Mass Index | 26 | 2023 | 12844 | 0.780 |
Why?
|
Risk Factors | 112 | 2024 | 73898 | 0.760 |
Why?
|
Middle Aged | 175 | 2024 | 218357 | 0.750 |
Why?
|
Glutathione Transferase | 5 | 2011 | 563 | 0.720 |
Why?
|
Female | 233 | 2024 | 388229 | 0.720 |
Why?
|
Ovarian Neoplasms | 16 | 2023 | 4876 | 0.720 |
Why?
|
Glucuronosyltransferase | 5 | 2012 | 130 | 0.690 |
Why?
|
Alleles | 30 | 2021 | 6886 | 0.680 |
Why?
|
Carbon | 2 | 2013 | 671 | 0.660 |
Why?
|
DNA Methylation | 15 | 2024 | 4323 | 0.640 |
Why?
|
Estradiol | 9 | 2012 | 1942 | 0.640 |
Why?
|
Humans | 292 | 2024 | 756111 | 0.610 |
Why?
|
Genetic Loci | 10 | 2017 | 2610 | 0.600 |
Why?
|
Coffee | 3 | 2020 | 582 | 0.590 |
Why?
|
Arylamine N-Acetyltransferase | 4 | 2023 | 85 | 0.580 |
Why?
|
Adult | 141 | 2024 | 218302 | 0.580 |
Why?
|
Genetic Variation | 18 | 2021 | 6506 | 0.580 |
Why?
|
Postmenopause | 8 | 2012 | 2495 | 0.560 |
Why?
|
Diet | 14 | 2023 | 7965 | 0.560 |
Why?
|
Vitamin D | 4 | 2015 | 3276 | 0.560 |
Why?
|
Smoking | 24 | 2017 | 9054 | 0.550 |
Why?
|
Aromatase | 6 | 2009 | 147 | 0.520 |
Why?
|
Diet, Mediterranean | 3 | 2020 | 726 | 0.510 |
Why?
|
Prospective Studies | 69 | 2023 | 54040 | 0.510 |
Why?
|
Paternal Age | 2 | 2012 | 87 | 0.510 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 2 | 2008 | 367 | 0.490 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 5 | 2008 | 253 | 0.490 |
Why?
|
Aged | 98 | 2024 | 167585 | 0.460 |
Why?
|
Haplotypes | 12 | 2014 | 2759 | 0.460 |
Why?
|
Gene Frequency | 13 | 2024 | 3588 | 0.450 |
Why?
|
Skin Neoplasms | 13 | 2020 | 5785 | 0.440 |
Why?
|
Metabolic Networks and Pathways | 3 | 2017 | 786 | 0.430 |
Why?
|
Phobic Disorders | 3 | 2018 | 436 | 0.430 |
Why?
|
Sex Hormone-Binding Globulin | 2 | 2012 | 545 | 0.420 |
Why?
|
Talc | 2 | 2010 | 48 | 0.420 |
Why?
|
Carcinoma, Basal Cell | 6 | 2016 | 557 | 0.420 |
Why?
|
Breast Neoplasms | 22 | 2015 | 20889 | 0.410 |
Why?
|
Menarche | 3 | 2024 | 528 | 0.400 |
Why?
|
Catechol O-Methyltransferase | 2 | 2004 | 250 | 0.400 |
Why?
|
Caffeine | 5 | 2020 | 697 | 0.400 |
Why?
|
Social Class | 4 | 2023 | 1996 | 0.380 |
Why?
|
Risk | 19 | 2024 | 9626 | 0.380 |
Why?
|
Estradiol Dehydrogenases | 1 | 2010 | 15 | 0.380 |
Why?
|
Endometriosis | 4 | 2023 | 869 | 0.380 |
Why?
|
Cohort Studies | 47 | 2024 | 41121 | 0.370 |
Why?
|
17-Hydroxysteroid Dehydrogenases | 1 | 2010 | 55 | 0.370 |
Why?
|
Hydro-Lyases | 1 | 2010 | 93 | 0.370 |
Why?
|
Arthritis, Rheumatoid | 6 | 2016 | 3760 | 0.370 |
Why?
|
Life Change Events | 3 | 2024 | 951 | 0.370 |
Why?
|
Cross-Sectional Studies | 24 | 2024 | 25715 | 0.370 |
Why?
|
Vitamin B Complex | 1 | 2013 | 293 | 0.360 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2011 | 125 | 0.360 |
Why?
|
Estrone | 6 | 2010 | 233 | 0.360 |
Why?
|
Cholesterol Side-Chain Cleavage Enzyme | 1 | 2010 | 27 | 0.360 |
Why?
|
Menopause | 9 | 2024 | 1639 | 0.350 |
Why?
|
Polymerase Chain Reaction | 15 | 2016 | 6067 | 0.350 |
Why?
|
Puberty | 3 | 2024 | 494 | 0.340 |
Why?
|
Body Height | 3 | 2023 | 1564 | 0.340 |
Why?
|
Obesity | 14 | 2023 | 12847 | 0.340 |
Why?
|
Reproduction | 3 | 2015 | 646 | 0.330 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2011 | 268 | 0.330 |
Why?
|
Life Style | 8 | 2021 | 3864 | 0.330 |
Why?
|
Epigenesis, Genetic | 8 | 2024 | 3717 | 0.330 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2011 | 415 | 0.320 |
Why?
|
Perineum | 1 | 2010 | 210 | 0.320 |
Why?
|
Estrogen Replacement Therapy | 4 | 2010 | 1205 | 0.320 |
Why?
|
Hyperinsulinism | 2 | 2023 | 397 | 0.320 |
Why?
|
Leiomyoma | 3 | 2010 | 663 | 0.320 |
Why?
|
Antioxidants | 5 | 2021 | 1653 | 0.320 |
Why?
|
Receptors, Estrogen | 1 | 2017 | 2187 | 0.320 |
Why?
|
Logistic Models | 23 | 2023 | 13316 | 0.310 |
Why?
|
Neoplasms | 12 | 2023 | 21899 | 0.310 |
Why?
|
Carotenoids | 4 | 2007 | 619 | 0.310 |
Why?
|
Uterine Neoplasms | 4 | 2013 | 1444 | 0.300 |
Why?
|
Melanoma | 7 | 2020 | 5659 | 0.290 |
Why?
|
Maternal Exposure | 3 | 2019 | 1029 | 0.290 |
Why?
|
Pancreatic Neoplasms | 7 | 2021 | 5292 | 0.290 |
Why?
|
Male | 103 | 2024 | 356852 | 0.290 |
Why?
|
Epigenomics | 3 | 2024 | 928 | 0.280 |
Why?
|
Gene Dosage | 4 | 2016 | 1219 | 0.280 |
Why?
|
DNA | 8 | 2022 | 7222 | 0.280 |
Why?
|
Exercise | 3 | 2020 | 5758 | 0.280 |
Why?
|
Nutritional Status | 3 | 2018 | 1600 | 0.280 |
Why?
|
Nevus | 2 | 2020 | 205 | 0.280 |
Why?
|
Isoenzymes | 3 | 2006 | 1689 | 0.270 |
Why?
|
Receptors, Androgen | 4 | 2009 | 1070 | 0.270 |
Why?
|
Diet Records | 4 | 2016 | 424 | 0.270 |
Why?
|
Epidemiologic Methods | 1 | 2011 | 1341 | 0.270 |
Why?
|
GATA5 Transcription Factor | 1 | 2006 | 18 | 0.270 |
Why?
|
Vitamin B 12 | 2 | 2023 | 517 | 0.270 |
Why?
|
O(6)-Methylguanine-DNA Methyltransferase | 1 | 2006 | 83 | 0.270 |
Why?
|
Oxidative Stress | 10 | 2023 | 3065 | 0.260 |
Why?
|
Mitochondria | 5 | 2023 | 3575 | 0.260 |
Why?
|
Genes, p53 | 3 | 2007 | 712 | 0.260 |
Why?
|
Models, Genetic | 6 | 2020 | 3439 | 0.260 |
Why?
|
Research Design | 3 | 2022 | 6143 | 0.250 |
Why?
|
Women's Health | 8 | 2019 | 2053 | 0.250 |
Why?
|
Odds Ratio | 17 | 2016 | 9719 | 0.250 |
Why?
|
Multifactorial Inheritance | 4 | 2024 | 1339 | 0.250 |
Why?
|
Incidence | 15 | 2024 | 21259 | 0.240 |
Why?
|
Longevity | 3 | 2021 | 1037 | 0.240 |
Why?
|
Stress Disorders, Post-Traumatic | 7 | 2018 | 4505 | 0.240 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2005 | 190 | 0.240 |
Why?
|
Hydroxysteroid Dehydrogenases | 1 | 2004 | 29 | 0.230 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2007 | 2864 | 0.230 |
Why?
|
Polymorphism, Restriction Fragment Length | 2 | 2004 | 760 | 0.230 |
Why?
|
Androgens | 2 | 2009 | 1285 | 0.230 |
Why?
|
Dietary Supplements | 3 | 2023 | 3376 | 0.230 |
Why?
|
Amino Acid Substitution | 3 | 2004 | 1736 | 0.230 |
Why?
|
Insulin Resistance | 1 | 2018 | 3946 | 0.230 |
Why?
|
United States | 40 | 2024 | 71909 | 0.220 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2022 | 1374 | 0.220 |
Why?
|
Phenol | 1 | 2023 | 45 | 0.220 |
Why?
|
Testosterone | 2 | 2012 | 2466 | 0.220 |
Why?
|
Genetic Association Studies | 6 | 2016 | 2706 | 0.220 |
Why?
|
Fatty Acids, Omega-3 | 2 | 2022 | 1385 | 0.220 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2011 | 1917 | 0.210 |
Why?
|
Depression | 7 | 2020 | 7960 | 0.210 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2004 | 275 | 0.210 |
Why?
|
Sequence Analysis, DNA | 5 | 2018 | 4703 | 0.210 |
Why?
|
Proportional Hazards Models | 9 | 2020 | 12503 | 0.210 |
Why?
|
Petroleum | 1 | 2022 | 80 | 0.210 |
Why?
|
Mosaicism | 2 | 2016 | 457 | 0.210 |
Why?
|
Intercellular Signaling Peptides and Proteins | 3 | 2019 | 1646 | 0.200 |
Why?
|
Confidence Intervals | 7 | 2013 | 2936 | 0.200 |
Why?
|
Steroid 17-alpha-Hydroxylase | 2 | 2003 | 99 | 0.200 |
Why?
|
Follow-Up Studies | 22 | 2023 | 39187 | 0.200 |
Why?
|
DNA Damage | 4 | 2021 | 2418 | 0.200 |
Why?
|
Mendelian Randomization Analysis | 3 | 2022 | 979 | 0.200 |
Why?
|
Germ-Line Mutation | 3 | 2017 | 1826 | 0.200 |
Why?
|
Phenols | 2 | 2023 | 514 | 0.200 |
Why?
|
PPAR gamma | 1 | 2004 | 485 | 0.200 |
Why?
|
Age Factors | 15 | 2021 | 18372 | 0.190 |
Why?
|
Environment | 2 | 2023 | 1116 | 0.190 |
Why?
|
Least-Squares Analysis | 2 | 2012 | 368 | 0.190 |
Why?
|
Diet Surveys | 2 | 2016 | 1160 | 0.190 |
Why?
|
Myelodysplastic Syndromes | 2 | 2021 | 1377 | 0.190 |
Why?
|
Phosphoproteins | 1 | 2010 | 2432 | 0.190 |
Why?
|
Gonadal Steroid Hormones | 2 | 2017 | 703 | 0.190 |
Why?
|
Anxiety Disorders | 1 | 2012 | 2707 | 0.190 |
Why?
|
Insulin | 2 | 2020 | 6571 | 0.180 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2003 | 330 | 0.180 |
Why?
|
Barrett Esophagus | 2 | 2019 | 492 | 0.180 |
Why?
|
Risk Assessment | 14 | 2020 | 23956 | 0.180 |
Why?
|
Apolipoprotein E4 | 2 | 2024 | 689 | 0.180 |
Why?
|
DNA Repair | 5 | 2021 | 2022 | 0.180 |
Why?
|
Chromosomes, Human, Pair 18 | 2 | 2011 | 246 | 0.180 |
Why?
|
Urogenital Neoplasms | 1 | 2021 | 135 | 0.180 |
Why?
|
Cognition | 4 | 2024 | 6906 | 0.170 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2002 | 412 | 0.170 |
Why?
|
Osteosarcoma | 2 | 2023 | 898 | 0.170 |
Why?
|
Mutation, Missense | 3 | 2009 | 2554 | 0.170 |
Why?
|
Triclosan | 1 | 2019 | 57 | 0.170 |
Why?
|
Longitudinal Studies | 14 | 2023 | 14393 | 0.170 |
Why?
|
Membrane Proteins | 6 | 2023 | 7825 | 0.170 |
Why?
|
Occupational Diseases | 4 | 2014 | 1484 | 0.160 |
Why?
|
Cholecalciferol | 1 | 2024 | 543 | 0.160 |
Why?
|
Phosphoric Monoester Hydrolases | 2 | 2000 | 418 | 0.160 |
Why?
|
Ovary | 2 | 2021 | 961 | 0.160 |
Why?
|
Occupational Exposure | 3 | 2021 | 1801 | 0.160 |
Why?
|
Linkage Disequilibrium | 9 | 2016 | 1990 | 0.160 |
Why?
|
Astronauts | 1 | 2019 | 92 | 0.150 |
Why?
|
Flavonols | 1 | 2018 | 84 | 0.150 |
Why?
|
Siblings | 2 | 2020 | 825 | 0.150 |
Why?
|
Vinyl Chloride | 2 | 1996 | 15 | 0.150 |
Why?
|
Cholesterol, HDL | 3 | 2022 | 1811 | 0.150 |
Why?
|
Inflammation | 8 | 2023 | 10716 | 0.150 |
Why?
|
Folic Acid | 4 | 2013 | 1299 | 0.150 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2018 | 8438 | 0.150 |
Why?
|
DNA-Binding Proteins | 8 | 2014 | 9561 | 0.150 |
Why?
|
Receptors, Adiponectin | 1 | 2018 | 81 | 0.150 |
Why?
|
Colorectal Neoplasms | 4 | 2022 | 6824 | 0.150 |
Why?
|
Mammals | 1 | 2023 | 1133 | 0.150 |
Why?
|
Aged, 80 and over | 19 | 2024 | 58608 | 0.150 |
Why?
|
Cacao | 1 | 2018 | 98 | 0.150 |
Why?
|
Cell Survival | 2 | 2023 | 5780 | 0.150 |
Why?
|
Particulate Matter | 4 | 2018 | 2539 | 0.150 |
Why?
|
Estrogens | 4 | 2015 | 1520 | 0.140 |
Why?
|
Prognosis | 14 | 2020 | 29463 | 0.140 |
Why?
|
Smoke | 1 | 2019 | 231 | 0.140 |
Why?
|
Cooking | 2 | 2022 | 311 | 0.140 |
Why?
|
Stress, Psychological | 4 | 2024 | 4386 | 0.140 |
Why?
|
Ribonucleoproteins | 2 | 2017 | 379 | 0.140 |
Why?
|
Health Surveys | 6 | 2020 | 4052 | 0.140 |
Why?
|
Chromosomes, Human, Pair 22 | 2 | 2010 | 345 | 0.140 |
Why?
|
Arachidonic Acid | 1 | 2018 | 435 | 0.140 |
Why?
|
Apoptosis | 4 | 2009 | 9445 | 0.140 |
Why?
|
Life Expectancy | 1 | 2023 | 1248 | 0.140 |
Why?
|
N-Glycosyl Hydrolases | 1 | 2016 | 68 | 0.140 |
Why?
|
Residence Characteristics | 3 | 2023 | 2031 | 0.140 |
Why?
|
Endocrine Disruptors | 1 | 2019 | 262 | 0.140 |
Why?
|
Temperament | 1 | 2018 | 289 | 0.130 |
Why?
|
Space Flight | 1 | 2019 | 213 | 0.130 |
Why?
|
Receptors, Leptin | 1 | 2018 | 349 | 0.130 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 3154 | 0.130 |
Why?
|
Thioredoxin Reductase 2 | 1 | 2016 | 25 | 0.130 |
Why?
|
Retinoid X Receptor alpha | 1 | 2015 | 16 | 0.130 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2000 | 588 | 0.130 |
Why?
|
Alcohol Drinking | 4 | 2020 | 3998 | 0.130 |
Why?
|
DNA, Neoplasm | 5 | 2012 | 1746 | 0.130 |
Why?
|
Disease-Free Survival | 4 | 2021 | 6806 | 0.130 |
Why?
|
Anesthetics, Inhalation | 1 | 2021 | 574 | 0.130 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 2016 | 127 | 0.130 |
Why?
|
Genes, Tumor Suppressor | 1 | 2000 | 1058 | 0.130 |
Why?
|
Fertilization in Vitro | 1 | 2003 | 1283 | 0.130 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2021 | 12203 | 0.130 |
Why?
|
Chromosomes, Human, Pair 5 | 2 | 2014 | 385 | 0.130 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2016 | 195 | 0.130 |
Why?
|
Population Groups | 1 | 2016 | 211 | 0.130 |
Why?
|
ROC Curve | 1 | 2023 | 3561 | 0.120 |
Why?
|
Homocysteine | 1 | 2018 | 638 | 0.120 |
Why?
|
Birth Weight | 1 | 2023 | 2076 | 0.120 |
Why?
|
Air Pollution, Indoor | 1 | 2022 | 885 | 0.120 |
Why?
|
Gene Expression Profiling | 3 | 2016 | 9341 | 0.120 |
Why?
|
Depressive Disorder, Major | 4 | 2018 | 4723 | 0.120 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2016 | 376 | 0.120 |
Why?
|
Phthalic Acids | 1 | 2019 | 474 | 0.120 |
Why?
|
Estrogen Receptor alpha | 2 | 2017 | 578 | 0.120 |
Why?
|
Carcinogens | 2 | 2012 | 449 | 0.120 |
Why?
|
Memory | 1 | 2024 | 2184 | 0.120 |
Why?
|
Phenotype | 9 | 2020 | 16442 | 0.120 |
Why?
|
Menstrual Cycle | 2 | 2015 | 533 | 0.120 |
Why?
|
Estrogen Receptor beta | 1 | 2015 | 169 | 0.120 |
Why?
|
Pilot Projects | 5 | 2023 | 8498 | 0.120 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2014 | 48 | 0.120 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2011 | 1129 | 0.120 |
Why?
|
Chromosomes, Human, X | 1 | 2016 | 316 | 0.120 |
Why?
|
Genome, Human | 3 | 2015 | 4391 | 0.120 |
Why?
|
Cholesterol, LDL | 2 | 2022 | 2416 | 0.120 |
Why?
|
Caregivers | 2 | 2018 | 2192 | 0.120 |
Why?
|
Tumor Burden | 1 | 2020 | 1888 | 0.120 |
Why?
|
Cyclin E | 1 | 2014 | 157 | 0.120 |
Why?
|
Vesicular Monoamine Transport Proteins | 1 | 2014 | 32 | 0.120 |
Why?
|
X Chromosome Inactivation | 1 | 2016 | 225 | 0.120 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2016 | 4019 | 0.120 |
Why?
|
Apolipoproteins E | 3 | 2024 | 1430 | 0.110 |
Why?
|
Eicosapentaenoic Acid | 1 | 2018 | 611 | 0.110 |
Why?
|
MicroRNAs | 2 | 2022 | 3774 | 0.110 |
Why?
|
Receptor, Insulin | 1 | 2018 | 834 | 0.110 |
Why?
|
Transplantation Conditioning | 1 | 2020 | 1591 | 0.110 |
Why?
|
Body Fat Distribution | 1 | 2015 | 242 | 0.110 |
Why?
|
Work Schedule Tolerance | 2 | 2023 | 551 | 0.110 |
Why?
|
Triglycerides | 2 | 2020 | 2472 | 0.110 |
Why?
|
Casein Kinase II | 1 | 2014 | 122 | 0.110 |
Why?
|
Lung Diseases, Interstitial | 1 | 2022 | 890 | 0.110 |
Why?
|
Predictive Value of Tests | 2 | 2020 | 15228 | 0.110 |
Why?
|
Saliva | 2 | 2015 | 815 | 0.110 |
Why?
|
Genes, ras | 3 | 2008 | 655 | 0.110 |
Why?
|
Hepatocyte Nuclear Factor 1-beta | 1 | 2013 | 92 | 0.110 |
Why?
|
Dementia | 1 | 2008 | 2601 | 0.110 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2014 | 350 | 0.110 |
Why?
|
Gallstones | 1 | 2016 | 285 | 0.110 |
Why?
|
Health Behavior | 2 | 2016 | 2619 | 0.110 |
Why?
|
Leukocytes, Mononuclear | 1 | 2020 | 1824 | 0.110 |
Why?
|
Europe | 6 | 2021 | 3415 | 0.110 |
Why?
|
Welding | 1 | 2014 | 89 | 0.110 |
Why?
|
Intrauterine Devices | 1 | 2014 | 113 | 0.110 |
Why?
|
Antigens, CD | 2 | 2018 | 3909 | 0.110 |
Why?
|
Adolescent | 19 | 2024 | 87297 | 0.110 |
Why?
|
Epidemiologic Studies | 4 | 2018 | 669 | 0.110 |
Why?
|
Mutagens | 1 | 2014 | 177 | 0.110 |
Why?
|
Polycyclic Compounds | 1 | 1992 | 29 | 0.110 |
Why?
|
Mixed Tumor, Mullerian | 1 | 2013 | 56 | 0.110 |
Why?
|
Love | 1 | 2013 | 38 | 0.110 |
Why?
|
Intestinal Polyps | 1 | 1993 | 104 | 0.110 |
Why?
|
Anemia, Aplastic | 1 | 2015 | 228 | 0.110 |
Why?
|
Hemangiosarcoma | 2 | 1996 | 218 | 0.100 |
Why?
|
Genetic Markers | 4 | 2023 | 2607 | 0.100 |
Why?
|
Critical Pathways | 1 | 2016 | 473 | 0.100 |
Why?
|
Carcinogens, Environmental | 1 | 1992 | 72 | 0.100 |
Why?
|
Cause of Death | 3 | 2020 | 3710 | 0.100 |
Why?
|
Child Abuse, Sexual | 1 | 2015 | 393 | 0.100 |
Why?
|
Adaptation, Physiological | 1 | 2019 | 1289 | 0.100 |
Why?
|
Genomic Instability | 2 | 2019 | 693 | 0.100 |
Why?
|
Vitamin D-Binding Protein | 1 | 2013 | 130 | 0.100 |
Why?
|
Disabled Children | 1 | 2014 | 251 | 0.100 |
Why?
|
Stem Cell Transplantation | 1 | 2020 | 1602 | 0.100 |
Why?
|
Alzheimer Disease | 2 | 2024 | 8459 | 0.100 |
Why?
|
Nepal | 2 | 2023 | 300 | 0.100 |
Why?
|
Adiponectin | 1 | 2018 | 1113 | 0.100 |
Why?
|
Genomic Imprinting | 3 | 2017 | 330 | 0.100 |
Why?
|
Vitamin B 6 | 1 | 2013 | 229 | 0.100 |
Why?
|
Cell Division | 2 | 1998 | 4448 | 0.100 |
Why?
|
Interleukin-12 Subunit p35 | 1 | 2011 | 22 | 0.100 |
Why?
|
Spinal Cord Injuries | 1 | 2019 | 920 | 0.100 |
Why?
|
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 1 | 2011 | 51 | 0.100 |
Why?
|
Occupations | 1 | 2014 | 513 | 0.100 |
Why?
|
Proto-Oncogene Proteins | 4 | 2014 | 4489 | 0.100 |
Why?
|
Sex Factors | 4 | 2020 | 10491 | 0.100 |
Why?
|
Socioeconomic Factors | 6 | 2024 | 7786 | 0.090 |
Why?
|
Cell Proliferation | 2 | 2023 | 10382 | 0.090 |
Why?
|
Prostatic Neoplasms | 4 | 2023 | 11312 | 0.090 |
Why?
|
Chromosome Aberrations | 2 | 2015 | 1767 | 0.090 |
Why?
|
Infant, Premature | 1 | 2021 | 2081 | 0.090 |
Why?
|
Premenopause | 3 | 2008 | 1036 | 0.090 |
Why?
|
Depressive Disorder | 3 | 2019 | 3731 | 0.090 |
Why?
|
Choline | 1 | 2013 | 513 | 0.090 |
Why?
|
Neoplasm Proteins | 2 | 2014 | 3606 | 0.090 |
Why?
|
Inhalation Exposure | 1 | 2014 | 429 | 0.090 |
Why?
|
Neoplasms, Basal Cell | 1 | 2010 | 31 | 0.090 |
Why?
|
Leukocyte Count | 1 | 2014 | 1590 | 0.090 |
Why?
|
Receptors, Calcitriol | 1 | 2013 | 355 | 0.090 |
Why?
|
Psychosocial Deprivation | 1 | 2011 | 99 | 0.090 |
Why?
|
Methionine | 1 | 2013 | 567 | 0.090 |
Why?
|
Receptor, Melanocortin, Type 4 | 1 | 2011 | 128 | 0.090 |
Why?
|
Oncogene Proteins | 1 | 2014 | 722 | 0.090 |
Why?
|
Neoplasms, Squamous Cell | 1 | 2010 | 96 | 0.090 |
Why?
|
Environmental Pollutants | 1 | 2019 | 1241 | 0.090 |
Why?
|
Carcinoma, Endometrioid | 1 | 2013 | 277 | 0.090 |
Why?
|
Neoplasm Invasiveness | 4 | 2015 | 3608 | 0.090 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2013 | 696 | 0.090 |
Why?
|
Hypothalamus | 1 | 2015 | 997 | 0.090 |
Why?
|
Gene Expression | 2 | 2021 | 7582 | 0.090 |
Why?
|
Child, Institutionalized | 1 | 2011 | 105 | 0.090 |
Why?
|
Meditation | 1 | 2013 | 249 | 0.090 |
Why?
|
Tumor Suppressor Proteins | 1 | 2000 | 2801 | 0.090 |
Why?
|
Cognition Disorders | 3 | 2011 | 3971 | 0.090 |
Why?
|
Anesthesia | 1 | 2021 | 1569 | 0.080 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2010 | 313 | 0.080 |
Why?
|
Quantitative Trait Loci | 4 | 2020 | 2074 | 0.080 |
Why?
|
Probability | 2 | 2021 | 2479 | 0.080 |
Why?
|
Maternal Age | 1 | 2012 | 804 | 0.080 |
Why?
|
Reference Values | 3 | 2007 | 4919 | 0.080 |
Why?
|
Lymphoma, B-Cell | 1 | 2016 | 930 | 0.080 |
Why?
|
Glaucoma, Open-Angle | 1 | 2016 | 728 | 0.080 |
Why?
|
Linear Models | 3 | 2017 | 5864 | 0.080 |
Why?
|
Lung Neoplasms | 8 | 2020 | 13221 | 0.080 |
Why?
|
Resilience, Psychological | 1 | 2016 | 737 | 0.080 |
Why?
|
BRCA1 Protein | 1 | 2015 | 1134 | 0.080 |
Why?
|
Nails | 2 | 2014 | 294 | 0.080 |
Why?
|
Breast Feeding | 1 | 2017 | 1355 | 0.080 |
Why?
|
Kv1.5 Potassium Channel | 1 | 2008 | 5 | 0.080 |
Why?
|
Young Adult | 14 | 2023 | 58143 | 0.080 |
Why?
|
Parturition | 1 | 2012 | 444 | 0.080 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2009 | 359 | 0.080 |
Why?
|
Forkhead Transcription Factors | 1 | 2016 | 1595 | 0.080 |
Why?
|
Codon | 2 | 2004 | 602 | 0.080 |
Why?
|
Rhodopsin | 1 | 2009 | 203 | 0.080 |
Why?
|
Anthropometry | 2 | 2016 | 1342 | 0.080 |
Why?
|
Reproducibility of Results | 5 | 2022 | 20002 | 0.080 |
Why?
|
Carrier Proteins | 2 | 1998 | 4939 | 0.080 |
Why?
|
Child Development | 1 | 2020 | 2269 | 0.080 |
Why?
|
Perception | 1 | 2014 | 1189 | 0.080 |
Why?
|
Child | 14 | 2024 | 79418 | 0.080 |
Why?
|
Adiposity | 1 | 2018 | 1846 | 0.080 |
Why?
|
HLA-DR Antigens | 1 | 2010 | 629 | 0.080 |
Why?
|
Hormones | 2 | 2003 | 871 | 0.080 |
Why?
|
Colonic Polyps | 1 | 1993 | 547 | 0.080 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2008 | 67 | 0.080 |
Why?
|
Calcium | 2 | 2013 | 5704 | 0.070 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2009 | 534 | 0.070 |
Why?
|
Hydrolases | 1 | 2008 | 146 | 0.070 |
Why?
|
Parents | 3 | 2020 | 3532 | 0.070 |
Why?
|
Base Sequence | 4 | 2009 | 12439 | 0.070 |
Why?
|
Cell Growth Processes | 1 | 2008 | 385 | 0.070 |
Why?
|
Disease Susceptibility | 2 | 2004 | 1776 | 0.070 |
Why?
|
Carcinoma in Situ | 1 | 2013 | 796 | 0.070 |
Why?
|
Prolactin | 1 | 2009 | 631 | 0.070 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2227 | 0.070 |
Why?
|
Metabolomics | 1 | 2016 | 1613 | 0.070 |
Why?
|
Neoplasm Staging | 5 | 2013 | 11106 | 0.070 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2008 | 297 | 0.070 |
Why?
|
Ethanol | 1 | 2013 | 1328 | 0.070 |
Why?
|
Venous Thromboembolism | 2 | 2017 | 1834 | 0.070 |
Why?
|
Alanine | 2 | 2009 | 593 | 0.070 |
Why?
|
Environmental Exposure | 2 | 2019 | 4357 | 0.070 |
Why?
|
Promoter Regions, Genetic | 4 | 2006 | 5787 | 0.070 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 1994 | 1704 | 0.070 |
Why?
|
CpG Islands | 2 | 2022 | 1208 | 0.070 |
Why?
|
NFATC Transcription Factors | 1 | 2008 | 380 | 0.070 |
Why?
|
Infant | 8 | 2023 | 35828 | 0.070 |
Why?
|
Membrane Transport Proteins | 1 | 2011 | 1036 | 0.060 |
Why?
|
Hematopoietic Stem Cells | 2 | 2014 | 3364 | 0.060 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2008 | 715 | 0.060 |
Why?
|
Regression Analysis | 3 | 2014 | 6362 | 0.060 |
Why?
|
Sex Characteristics | 4 | 2024 | 2631 | 0.060 |
Why?
|
Retinitis Pigmentosa | 1 | 2009 | 395 | 0.060 |
Why?
|
Tissue Donors | 1 | 2015 | 2263 | 0.060 |
Why?
|
Self Report | 2 | 2018 | 3677 | 0.060 |
Why?
|
B-Lymphocytes | 1 | 1998 | 4707 | 0.060 |
Why?
|
Animals | 12 | 2024 | 167069 | 0.060 |
Why?
|
Meta-Analysis as Topic | 3 | 2014 | 1370 | 0.060 |
Why?
|
Androstenedione | 1 | 2004 | 131 | 0.060 |
Why?
|
Stromal Cells | 1 | 2010 | 1317 | 0.060 |
Why?
|
Body Size | 1 | 2007 | 462 | 0.060 |
Why?
|
Air Pollution | 1 | 2018 | 2303 | 0.060 |
Why?
|
Neuroendocrine Tumors | 1 | 2011 | 645 | 0.060 |
Why?
|
Flavonoids | 1 | 2007 | 445 | 0.060 |
Why?
|
Air Pollutants | 1 | 2018 | 2823 | 0.060 |
Why?
|
Estrogens, Catechol | 1 | 2004 | 25 | 0.060 |
Why?
|
Survival Rate | 4 | 2021 | 12790 | 0.060 |
Why?
|
Hematologic Neoplasms | 1 | 2016 | 1882 | 0.060 |
Why?
|
Glucuronides | 1 | 2004 | 20 | 0.060 |
Why?
|
Trinucleotide Repeats | 1 | 2005 | 257 | 0.060 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2008 | 487 | 0.060 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2006 | 296 | 0.060 |
Why?
|
Rectal Neoplasms | 1 | 1993 | 1149 | 0.060 |
Why?
|
Hypertension | 1 | 2024 | 8532 | 0.060 |
Why?
|
Ketone Bodies | 1 | 2023 | 76 | 0.060 |
Why?
|
Proteins | 3 | 2014 | 6026 | 0.060 |
Why?
|
Lung | 3 | 2022 | 9924 | 0.060 |
Why?
|
Puberty, Delayed | 1 | 2024 | 121 | 0.060 |
Why?
|
Genomics | 2 | 2016 | 5742 | 0.060 |
Why?
|
RNA | 1 | 2013 | 2711 | 0.050 |
Why?
|
Anxiety | 1 | 2018 | 4481 | 0.050 |
Why?
|
Child, Preschool | 7 | 2022 | 41848 | 0.050 |
Why?
|
Pregnancy | 7 | 2020 | 29548 | 0.050 |
Why?
|
Mutation | 6 | 2017 | 29764 | 0.050 |
Why?
|
Acetaminophen | 1 | 2007 | 549 | 0.050 |
Why?
|
Leucine | 1 | 2004 | 550 | 0.050 |
Why?
|
Neuropsychological Tests | 3 | 2024 | 6990 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2019 | 10256 | 0.050 |
Why?
|
Puberty, Precocious | 1 | 2024 | 162 | 0.050 |
Why?
|
Valine | 1 | 2004 | 407 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2011 | 2818 | 0.050 |
Why?
|
Organ Size | 1 | 2008 | 2248 | 0.050 |
Why?
|
Selenium | 1 | 2005 | 416 | 0.050 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2023 | 119 | 0.050 |
Why?
|
Hypertriglyceridemia | 1 | 2006 | 315 | 0.050 |
Why?
|
Infant, Newborn | 5 | 2021 | 26034 | 0.050 |
Why?
|
Health Resources | 1 | 2009 | 923 | 0.050 |
Why?
|
Double-Blind Method | 2 | 2023 | 12353 | 0.050 |
Why?
|
Poland | 2 | 2012 | 196 | 0.050 |
Why?
|
Australia | 3 | 2012 | 1283 | 0.050 |
Why?
|
Codon, Terminator | 1 | 2002 | 125 | 0.050 |
Why?
|
Cell Line, Tumor | 3 | 2008 | 16782 | 0.050 |
Why?
|
Adenoma | 1 | 1993 | 2146 | 0.050 |
Why?
|
beta Carotene | 1 | 2003 | 524 | 0.050 |
Why?
|
Sleep | 2 | 2023 | 4717 | 0.050 |
Why?
|
Fertility | 2 | 2021 | 775 | 0.050 |
Why?
|
Massachusetts | 5 | 2015 | 8733 | 0.050 |
Why?
|
Cardiovascular Diseases | 4 | 2017 | 15659 | 0.050 |
Why?
|
Educational Status | 2 | 2024 | 2509 | 0.050 |
Why?
|
Motor Activity | 1 | 2012 | 2688 | 0.050 |
Why?
|
Liver Neoplasms | 2 | 1996 | 4296 | 0.050 |
Why?
|
Age Distribution | 1 | 2007 | 2888 | 0.050 |
Why?
|
Embryo Implantation | 1 | 2003 | 270 | 0.050 |
Why?
|
Sarcoma | 1 | 2013 | 1788 | 0.050 |
Why?
|
Personality Inventory | 1 | 2004 | 1020 | 0.050 |
Why?
|
Ultraviolet Rays | 2 | 2016 | 1076 | 0.050 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2022 | 227 | 0.050 |
Why?
|
Statistics, Nonparametric | 1 | 2007 | 2849 | 0.050 |
Why?
|
Endometrium | 1 | 2004 | 405 | 0.050 |
Why?
|
Multivariate Analysis | 2 | 2013 | 12160 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4569 | 0.050 |
Why?
|
Epithelial Cells | 2 | 2010 | 3668 | 0.050 |
Why?
|
Calcium-Binding Proteins | 2 | 2017 | 1063 | 0.050 |
Why?
|
Fetal Blood | 2 | 2018 | 1330 | 0.050 |
Why?
|
Hospitalization | 1 | 2021 | 10683 | 0.050 |
Why?
|
Primary Ovarian Insufficiency | 1 | 2021 | 106 | 0.050 |
Why?
|
Survival Analysis | 3 | 2020 | 10183 | 0.050 |
Why?
|
Fragile X Mental Retardation Protein | 1 | 2021 | 117 | 0.050 |
Why?
|
Endophenotypes | 1 | 2022 | 251 | 0.050 |
Why?
|
Vitamin D Deficiency | 1 | 2010 | 1370 | 0.050 |
Why?
|
Mouth Mucosa | 1 | 2003 | 428 | 0.040 |
Why?
|
Molecular Sequence Data | 5 | 2009 | 17607 | 0.040 |
Why?
|
China | 3 | 2012 | 2343 | 0.040 |
Why?
|
Nitrous Oxide | 1 | 2021 | 166 | 0.040 |
Why?
|
Signal Transduction | 4 | 2018 | 23254 | 0.040 |
Why?
|
Menopause, Premature | 1 | 2021 | 126 | 0.040 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 2000 | 331 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2014 | 3947 | 0.040 |
Why?
|
Population Surveillance | 1 | 2010 | 2608 | 0.040 |
Why?
|
Epidemiologic Research Design | 1 | 2003 | 367 | 0.040 |
Why?
|
Substrate Specificity | 1 | 2004 | 1790 | 0.040 |
Why?
|
Social Justice | 1 | 2024 | 473 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2022 | 3772 | 0.040 |
Why?
|
United States National Aeronautics and Space Administration | 1 | 2019 | 15 | 0.040 |
Why?
|
Chi-Square Distribution | 3 | 2014 | 3471 | 0.040 |
Why?
|
Wheelchairs | 1 | 2019 | 77 | 0.040 |
Why?
|
Vitamins | 2 | 2005 | 1634 | 0.040 |
Why?
|
Brain Ischemia | 1 | 2013 | 3128 | 0.040 |
Why?
|
Melphalan | 1 | 2020 | 421 | 0.040 |
Why?
|
Mental Disorders | 1 | 2019 | 6794 | 0.040 |
Why?
|
Binding Sites | 2 | 2006 | 6038 | 0.040 |
Why?
|
Nitrosamines | 1 | 2019 | 84 | 0.040 |
Why?
|
Flavanones | 1 | 2019 | 73 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 853 | 0.040 |
Why?
|
Nutrition Surveys | 2 | 2020 | 1714 | 0.040 |
Why?
|
Growth Disorders | 1 | 2023 | 626 | 0.040 |
Why?
|
Glioma | 1 | 2013 | 3400 | 0.040 |
Why?
|
Germ Cells | 1 | 2022 | 633 | 0.040 |
Why?
|
Urinary Bladder Diseases | 1 | 2019 | 170 | 0.040 |
Why?
|
Catechin | 1 | 2018 | 69 | 0.040 |
Why?
|
Oxidants | 1 | 2019 | 168 | 0.040 |
Why?
|
Women | 1 | 2020 | 226 | 0.040 |
Why?
|
Air Pollutants, Occupational | 1 | 2021 | 407 | 0.040 |
Why?
|
Group VI Phospholipases A2 | 1 | 2017 | 16 | 0.040 |
Why?
|
Fruit | 2 | 2019 | 1159 | 0.040 |
Why?
|
South Africa | 1 | 2023 | 1794 | 0.040 |
Why?
|
Vegetables | 2 | 2019 | 1195 | 0.040 |
Why?
|
Chromosome Mapping | 3 | 2012 | 4627 | 0.040 |
Why?
|
Spain | 2 | 2010 | 486 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2000 | 787 | 0.040 |
Why?
|
Microtubule-Associated Proteins | 1 | 2023 | 1075 | 0.040 |
Why?
|
Ketones | 1 | 2019 | 181 | 0.040 |
Why?
|
Placenta | 2 | 2017 | 1693 | 0.040 |
Why?
|
Caloric Restriction | 1 | 2020 | 290 | 0.040 |
Why?
|
Bone Neoplasms | 2 | 2023 | 2532 | 0.040 |
Why?
|
Isoflurane | 1 | 2021 | 384 | 0.040 |
Why?
|
Colonic Neoplasms | 1 | 2009 | 2510 | 0.040 |
Why?
|
Uterus | 1 | 2021 | 651 | 0.040 |
Why?
|
Fasting | 1 | 2023 | 1595 | 0.040 |
Why?
|
Dopamine | 1 | 2004 | 1582 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2008 | 10806 | 0.040 |
Why?
|
Chronic Disease | 3 | 2019 | 9202 | 0.040 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 2271 | 0.040 |
Why?
|
Bayes Theorem | 1 | 2005 | 2307 | 0.040 |
Why?
|
New Hampshire | 2 | 2008 | 173 | 0.030 |
Why?
|
Urinary Bladder | 2 | 2014 | 1170 | 0.030 |
Why?
|
Cotinine | 1 | 2017 | 203 | 0.030 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2024 | 1241 | 0.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5608 | 0.030 |
Why?
|
Personality Assessment | 1 | 2018 | 651 | 0.030 |
Why?
|
Heterozygote | 3 | 2009 | 2787 | 0.030 |
Why?
|
SEER Program | 1 | 2021 | 1524 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2017 | 1875 | 0.030 |
Why?
|
Genetic Drift | 1 | 2016 | 41 | 0.030 |
Why?
|
Cytochrome P-450 CYP1A1 | 2 | 2008 | 89 | 0.030 |
Why?
|
Registries | 3 | 2023 | 8402 | 0.030 |
Why?
|
Death Certificates | 1 | 2016 | 167 | 0.030 |
Why?
|
Molecular Epidemiology | 2 | 1996 | 460 | 0.030 |
Why?
|
Psychology | 1 | 2018 | 353 | 0.030 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 1998 | 460 | 0.030 |
Why?
|
Retroviridae | 1 | 1998 | 851 | 0.030 |
Why?
|
Dietary Fats | 1 | 2003 | 1987 | 0.030 |
Why?
|
Statistics as Topic | 1 | 2002 | 2361 | 0.030 |
Why?
|
Interleukin-1beta | 2 | 2014 | 999 | 0.030 |
Why?
|
Mice | 6 | 2024 | 80709 | 0.030 |
Why?
|
Causality | 1 | 2022 | 1237 | 0.030 |
Why?
|
Transduction, Genetic | 1 | 1998 | 896 | 0.030 |
Why?
|
Mobility Limitation | 1 | 2019 | 402 | 0.030 |
Why?
|
Hippocampus | 1 | 2008 | 3723 | 0.030 |
Why?
|
Health Occupations | 1 | 2016 | 222 | 0.030 |
Why?
|
Prejudice | 1 | 2019 | 564 | 0.030 |
Why?
|
Aspirin | 1 | 2007 | 3346 | 0.030 |
Why?
|
Fatty Acids | 1 | 2022 | 1803 | 0.030 |
Why?
|
Feeding Behavior | 2 | 2019 | 3180 | 0.030 |
Why?
|
Carotid Arteries | 1 | 2019 | 951 | 0.030 |
Why?
|
Receptors, GABA-B | 1 | 2014 | 58 | 0.030 |
Why?
|
Karyotyping | 1 | 2016 | 1181 | 0.030 |
Why?
|
Exercise Tolerance | 1 | 2019 | 809 | 0.030 |
Why?
|
Protein Isoforms | 2 | 2012 | 1698 | 0.030 |
Why?
|
Epistasis, Genetic | 1 | 2016 | 349 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2000 | 1114 | 0.030 |
Why?
|
Exons | 1 | 2000 | 2385 | 0.030 |
Why?
|
Homozygote | 2 | 2009 | 1783 | 0.030 |
Why?
|
Potassium Channels, Tandem Pore Domain | 1 | 2014 | 57 | 0.030 |
Why?
|
Labor Unions | 1 | 2014 | 48 | 0.030 |
Why?
|
Chile | 1 | 2014 | 246 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2019 | 721 | 0.030 |
Why?
|
Waist-Hip Ratio | 1 | 2015 | 516 | 0.030 |
Why?
|
Nicotine | 1 | 2019 | 676 | 0.030 |
Why?
|
HLA Antigens | 1 | 2019 | 1355 | 0.030 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2021 | 830 | 0.030 |
Why?
|
Prevalence | 3 | 2017 | 15599 | 0.030 |
Why?
|
Prefrontal Cortex | 1 | 2004 | 2204 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2015 | 551 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2013 | 14654 | 0.030 |
Why?
|
Parkinson Disease | 1 | 2008 | 2841 | 0.030 |
Why?
|
Receptors, Retinoic Acid | 1 | 2014 | 226 | 0.030 |
Why?
|
Alu Elements | 1 | 2014 | 114 | 0.030 |
Why?
|
Data Collection | 1 | 2023 | 3306 | 0.030 |
Why?
|
Protein Binding | 3 | 2006 | 9300 | 0.030 |
Why?
|
Air | 1 | 2014 | 185 | 0.030 |
Why?
|
Carcinoma | 1 | 2004 | 2344 | 0.030 |
Why?
|
Weight Gain | 1 | 2023 | 2333 | 0.030 |
Why?
|
Sister Chromatid Exchange | 1 | 1992 | 60 | 0.030 |
Why?
|
Pigmentation | 1 | 2013 | 144 | 0.030 |
Why?
|
Genetic Pleiotropy | 1 | 2014 | 181 | 0.030 |
Why?
|
Glutathione S-Transferase pi | 2 | 2003 | 99 | 0.030 |
Why?
|
Michigan | 1 | 2013 | 340 | 0.030 |
Why?
|
Phylogeny | 1 | 2000 | 2754 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 1994 | 2899 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2023 | 2896 | 0.030 |
Why?
|
Metals, Heavy | 1 | 2014 | 145 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2000 | 6143 | 0.030 |
Why?
|
Algorithms | 2 | 2020 | 13940 | 0.030 |
Why?
|
Oncogene Proteins, Viral | 1 | 1994 | 341 | 0.030 |
Why?
|
tau Proteins | 1 | 2022 | 2059 | 0.030 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2014 | 330 | 0.020 |
Why?
|
Dioxygenases | 1 | 2014 | 336 | 0.020 |
Why?
|
Marital Status | 1 | 2013 | 432 | 0.020 |
Why?
|
Cholesterol | 2 | 2016 | 2923 | 0.020 |
Why?
|
Weight Loss | 1 | 2023 | 2669 | 0.020 |
Why?
|
Time Factors | 4 | 2019 | 39991 | 0.020 |
Why?
|
Sunlight | 1 | 2013 | 334 | 0.020 |
Why?
|
Computer Simulation | 1 | 2005 | 6190 | 0.020 |
Why?
|
Waist Circumference | 1 | 2015 | 921 | 0.020 |
Why?
|
Overweight | 1 | 2022 | 2402 | 0.020 |
Why?
|
Telomeric Repeat Binding Protein 1 | 1 | 2010 | 6 | 0.020 |
Why?
|
Hair Color | 1 | 2011 | 131 | 0.020 |
Why?
|
Contraception | 1 | 2014 | 345 | 0.020 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2008 | 5241 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2014 | 701 | 0.020 |
Why?
|
Bone and Bones | 1 | 2021 | 2552 | 0.020 |
Why?
|
Religion | 1 | 2014 | 373 | 0.020 |
Why?
|
Contraceptives, Oral | 1 | 2013 | 554 | 0.020 |
Why?
|
Risk Reduction Behavior | 1 | 2017 | 1098 | 0.020 |
Why?
|
Stroke | 1 | 2013 | 9911 | 0.020 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2014 | 701 | 0.020 |
Why?
|
Foster Home Care | 1 | 2011 | 132 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2017 | 1738 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2020 | 2869 | 0.020 |
Why?
|
Pedigree | 1 | 2017 | 4565 | 0.020 |
Why?
|
Selection Bias | 1 | 2011 | 357 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 1998 | 6118 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2022 | 3506 | 0.020 |
Why?
|
Testicular Neoplasms | 1 | 2015 | 798 | 0.020 |
Why?
|
Amyloid beta-Peptides | 1 | 2022 | 3805 | 0.020 |
Why?
|
MAP Kinase Kinase Kinase 1 | 1 | 2009 | 57 | 0.020 |
Why?
|
Parity | 1 | 2012 | 927 | 0.020 |
Why?
|
Finland | 1 | 2010 | 597 | 0.020 |
Why?
|
Cytochrome P-450 CYP1A2 | 1 | 2008 | 67 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2012 | 719 | 0.020 |
Why?
|
Transcription Factors | 3 | 2003 | 12069 | 0.020 |
Why?
|
Gestational Age | 1 | 2017 | 3557 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2016 | 1986 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2014 | 1163 | 0.020 |
Why?
|
HeLa Cells | 1 | 2014 | 3096 | 0.020 |
Why?
|
Comorbidity | 1 | 2023 | 10534 | 0.020 |
Why?
|
Inheritance Patterns | 1 | 2010 | 335 | 0.020 |
Why?
|
Camptothecin | 1 | 2012 | 581 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 1994 | 991 | 0.020 |
Why?
|
Microdissection | 1 | 2008 | 151 | 0.020 |
Why?
|
Body Weight | 1 | 2019 | 4608 | 0.020 |
Why?
|
Sample Size | 1 | 2011 | 838 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2010 | 956 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2013 | 1633 | 0.020 |
Why?
|
Fas Ligand Protein | 1 | 2008 | 214 | 0.020 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2010 | 781 | 0.020 |
Why?
|
Pain | 1 | 2023 | 5032 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2011 | 1575 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2013 | 11025 | 0.020 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2009 | 205 | 0.020 |
Why?
|
Patient Discharge | 1 | 2021 | 3452 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2016 | 1896 | 0.020 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2009 | 295 | 0.020 |
Why?
|
India | 1 | 2014 | 2325 | 0.020 |
Why?
|
Photoreceptor Cells, Vertebrate | 1 | 2009 | 203 | 0.020 |
Why?
|
Liver | 2 | 2012 | 7475 | 0.020 |
Why?
|
Precancerous Conditions | 1 | 1994 | 974 | 0.020 |
Why?
|
Electroretinography | 1 | 2009 | 516 | 0.020 |
Why?
|
Lipids | 1 | 2018 | 3334 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3926 | 0.020 |
Why?
|
Interleukin-2 | 1 | 2014 | 1872 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2015 | 1722 | 0.020 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2010 | 542 | 0.020 |
Why?
|
Seasons | 1 | 1992 | 1515 | 0.020 |
Why?
|
Chromatin | 1 | 2018 | 2926 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2010 | 79746 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2015 | 4665 | 0.020 |
Why?
|
Environmental Monitoring | 1 | 1992 | 1427 | 0.020 |
Why?
|
Genes, Dominant | 1 | 2009 | 864 | 0.020 |
Why?
|
Glycine | 1 | 2009 | 662 | 0.020 |
Why?
|
Pancreatic Ducts | 1 | 2008 | 329 | 0.020 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 1 | 2006 | 130 | 0.020 |
Why?
|
Public Health Nursing | 1 | 2005 | 14 | 0.020 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1400 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2014 | 6244 | 0.020 |
Why?
|
Models, Statistical | 2 | 2015 | 5062 | 0.020 |
Why?
|
Veterans | 1 | 2018 | 2615 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2008 | 2014 | 0.010 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2015 | 1623 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6523 | 0.010 |
Why?
|
Fats, Unsaturated | 1 | 2003 | 21 | 0.010 |
Why?
|
Lasers | 1 | 2008 | 954 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2014 | 2610 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2014 | 3203 | 0.010 |
Why?
|
DNA Ligases | 1 | 2003 | 82 | 0.010 |
Why?
|
Microfilament Proteins | 1 | 2009 | 1132 | 0.010 |
Why?
|
Clinical Protocols | 1 | 2009 | 1437 | 0.010 |
Why?
|
Nuclear Receptor Coactivator 3 | 1 | 2003 | 46 | 0.010 |
Why?
|
Epitopes | 1 | 2010 | 2502 | 0.010 |
Why?
|
Mice, SCID | 1 | 2008 | 2617 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 21780 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2013 | 2686 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8312 | 0.010 |
Why?
|
Violence | 1 | 2009 | 926 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2014 | 3472 | 0.010 |
Why?
|
Rad52 DNA Repair and Recombination Protein | 1 | 2002 | 30 | 0.010 |
Why?
|
Verbal Learning | 1 | 2005 | 465 | 0.010 |
Why?
|
Cells, Cultured | 1 | 1998 | 18929 | 0.010 |
Why?
|
Pregnancy Complications | 1 | 2016 | 2923 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 1994 | 3785 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2014 | 4342 | 0.010 |
Why?
|
International Cooperation | 1 | 2009 | 1429 | 0.010 |
Why?
|
Computational Biology | 1 | 2014 | 3486 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2014 | 3812 | 0.010 |
Why?
|
Proline | 1 | 2003 | 456 | 0.010 |
Why?
|
TATA Box | 1 | 2001 | 127 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15773 | 0.010 |
Why?
|
Body Composition | 1 | 2010 | 2415 | 0.010 |
Why?
|
Methyltransferases | 1 | 2003 | 372 | 0.010 |
Why?
|
Family | 1 | 2010 | 3188 | 0.010 |
Why?
|
Transcription, Genetic | 2 | 2006 | 7574 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13432 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2022 | 20421 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2009 | 6018 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 2015 | 4305 | 0.010 |
Why?
|
Memory, Short-Term | 1 | 2005 | 973 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2014 | 3343 | 0.010 |
Why?
|
Quality of Life | 1 | 2019 | 13215 | 0.010 |
Why?
|
Protein Tyrosine Phosphatases, Non-Receptor | 1 | 1998 | 68 | 0.010 |
Why?
|
Histone Chaperones | 1 | 1998 | 82 | 0.010 |
Why?
|
Databases, Factual | 1 | 2013 | 7943 | 0.010 |
Why?
|
Introns | 1 | 2000 | 974 | 0.010 |
Why?
|
Brain | 1 | 2024 | 26883 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2024 | 36181 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2003 | 64582 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2012 | 12755 | 0.010 |
Why?
|
Internet | 1 | 2009 | 3068 | 0.010 |
Why?
|
3T3 Cells | 1 | 1998 | 1085 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2001 | 1755 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 2011 | 4359 | 0.010 |
Why?
|
Conserved Sequence | 1 | 1998 | 1165 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2013 | 5846 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 1992 | 11881 | 0.010 |
Why?
|
France | 1 | 1996 | 508 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2006 | 3289 | 0.010 |
Why?
|
Silicosis | 1 | 1994 | 46 | 0.010 |
Why?
|
Asbestosis | 1 | 1994 | 82 | 0.010 |
Why?
|
Receptors, Growth Factor | 1 | 1995 | 326 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 1998 | 13425 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1998 | 2754 | 0.010 |
Why?
|
Receptor, erbB-2 | 2 | 1994 | 2487 | 0.010 |
Why?
|
Health Personnel | 1 | 2007 | 3284 | 0.010 |
Why?
|
Mass Screening | 1 | 2009 | 5411 | 0.010 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 1998 | 726 | 0.010 |
Why?
|
Growth Substances | 1 | 1995 | 764 | 0.010 |
Why?
|
Asbestos | 1 | 1994 | 253 | 0.010 |
Why?
|
Mammography | 1 | 2003 | 2439 | 0.010 |
Why?
|
Carcinoma, Small Cell | 1 | 1994 | 416 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 1998 | 3797 | 0.010 |
Why?
|
Immunoblotting | 1 | 1994 | 1650 | 0.010 |
Why?
|
GTP-Binding Proteins | 1 | 1995 | 947 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 1992 | 1229 | 0.010 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 1994 | 1086 | 0.000 |
Why?
|
Lymphatic Metastasis | 1 | 1994 | 2937 | 0.000 |
Why?
|
Myocardium | 1 | 1998 | 4682 | 0.000 |
Why?
|
Protein Conformation | 1 | 1992 | 3966 | 0.000 |
Why?
|
Carcinoma, Hepatocellular | 1 | 1996 | 2286 | 0.000 |
Why?
|
Cell Differentiation | 1 | 1998 | 11439 | 0.000 |
Why?
|
Peptides | 1 | 1992 | 4321 | 0.000 |
Why?
|